Can You Take Testosterone While Pregnant? No, It's Contraindicated
Testosterone cypionate is FDA Category X during pregnancy, risking irreversible virilization of a female fetus. Also contraindicated while breastfeeding.
Testosterone Cypionate
54 source-based articles maintained by the HealthRX.com Editorial Team.
54articles
7topic areas covered
May 25, 2026latest review
Testosterone Cypionate library
Showing 54 of 54 clinical reviews.
Does Aetna (CVS Health) Cover Testosterone Cypionate?
Aetna (CVS Health) covers testosterone cypionate for diagnosed male hypogonadism with prior authorization. Learn formulary tier, step therapy rules, PA criteria, appeal steps, and cost-saving strategies.
Does Anthem (Elevance Health) Cover Testosterone Cypionate?
A clinical and insurance guide to Anthem (Elevance Health) coverage of testosterone cypionate, including prior authorization criteria, step therapy requirements, formulary tier, and how to appeal a denial.
Does Blue Cross Blue Shield (Federated) Cover Testosterone Cypionate?
A clinical and insurance guide on Blue Cross Blue Shield (Federated) coverage for testosterone cypionate, including prior authorization criteria, formulary tiers, step therapy requirements, and how to appeal a denial.
Does Cigna Cover Testosterone Cypionate?
A clinical and practical guide to Cigna's coverage policies for testosterone cypionate, including prior authorization criteria, formulary tier, step therapy requirements, and how to appeal a denial.
Does Humana Cover Testosterone Cypionate?
Find out whether Humana covers testosterone cypionate for hypogonadism, including formulary tier, prior authorization requirements, step therapy rules, and how to appeal a denial.
Does Kaiser Permanente Cover Testosterone Cypionate?
A guide to Kaiser Permanente formulary status, prior authorization criteria, step therapy requirements, and appeal strategies for testosterone cypionate coverage.
Does Medicare Advantage Cover Testosterone Cypionate?
Medicare Advantage plans generally cover testosterone cypionate for diagnosed male hypogonadism under Part D formularies, but prior authorization and step therapy requirements vary by carrier.
Does State Medicaid Cover Testosterone Cypionate?
State Medicaid coverage for testosterone cypionate varies widely. Learn formulary tiers, prior authorization criteria, step therapy rules, and how to appeal a denial.
Does TRICARE Cover Testosterone Cypionate?
TRICARE covers testosterone cypionate for diagnosed male hypogonadism. Learn about formulary tier, prior authorization requirements, step therapy, appeal options, and out-of-pocket costs for military beneficiaries.
Does UnitedHealthcare Cover Testosterone Cypionate?
A detailed guide to UnitedHealthcare coverage for testosterone cypionate, including formulary tier, prior authorization criteria, step therapy requirements, and how to appeal a denial.
Injectable Testosterone and Liver Injury Risk (LiverTox Data)
LiverTox and T-Trials data show injectable testosterone cypionate bypasses first-pass liver metabolism and showed no significant ALT/AST rise at standard doses.
Testosterone Cypionate After 50: Put the Lab Result in Its Injection Cycle
Testosterone cypionate after 50: why diagnosis, injection timing, hematocrit and blood pressure matter more than an age-based starting dose.
Testosterone Cypionate Contract Manufacturing & Supply
See which FDA-approved manufacturers (Pfizer, Hikma) make testosterone cypionate, DEA quota limits, and the shortage history prescribers and patients should know.
Testosterone Cypionate Cost vs. Alternatives: A Full Comparison of TRT Options
Compare testosterone cypionate pricing, efficacy, and side-effect profiles against enanthate, undecanoate (Aveed), topical gels (AndroGel), patches, and oral jatenzo. Includes real-world cost data, trial evidence, and switching guidance.
Testosterone Cypionate Dosing for Adults Aged 30 to 49: Evidence-Based Guide
Complete guide to testosterone cypionate dosing for adults aged 30 to 49, including starting doses, titration schedules, injection frequency, monitoring labs, and dose adjustments based on clinical guidelines and trial data.
Testosterone Cypionate Dosing for Young Adults (18-29): Evidence-Based Protocols
Clinical guide to testosterone cypionate dosing in men aged 18-29, covering starting doses, titration, fertility preservation with hCG, and monitoring schedules backed by endocrine society guidelines.
Testosterone Cypionate Dosing in Hepatic Impairment
A guide to testosterone cypionate dosing, mechanism of action, and clinical management when liver function is compromised. Includes trial data, FDA label guidance, and a practical dosing framework.
Testosterone Cypionate Dosing in Renal Impairment
A clinician-level guide to testosterone cypionate dosing when kidney function is reduced, covering pharmacokinetics, monitoring, dose adjustment strategies, and evidence from primary sources.
Testosterone Cypionate Food & Supplement Interactions
Evidence-based guide to foods, supplements, and nutrients that interact with testosterone cypionate, including effects on absorption, metabolism, and clinical outcomes.
Testosterone Cypionate for Male Hypogonadism: Evidence, Dosing, and Clinical Guidance
A guide to testosterone cypionate for male hypogonadism covering FDA approval, T-Trials evidence, dosing protocols, monitoring, side effects, and insurance coverage.
Testosterone Cypionate for Secondary Hypogonadism: Evidence, Dosing, and Clinical Decisions
A guide to testosterone cypionate for secondary hypogonadism covering FDA approval status, T-Trials evidence, dosing protocols, fertility preservation, and monitoring benchmarks.
Testosterone Cypionate Future Formulations & Pipeline
A clinical overview of next-generation testosterone cypionate delivery systems, novel formulations in development, and pipeline compounds that may reshape TRT protocols.
Testosterone Cypionate Geriatric (65+) Dosing: Safe Starting Doses, Monitoring, and Adjustment
Evidence-based guide to testosterone cypionate dosing in men 65 and older, covering safe starting doses, monitoring protocols, cardiovascular considerations, and when to adjust or stop therapy.
Testosterone Cypionate Geriatric (65+) Monitoring: A Clinical Guide
Complete guide to monitoring testosterone cypionate therapy in men 65 and older, covering lab schedules, cardiovascular risk, falls risk, hematocrit targets, and deprescribing thresholds backed by the T-Trials and current endocrine guidelines.
Testosterone Cypionate Hair and Skin Changes: What to Expect and How to Manage Them
A guide to hair and skin changes linked to testosterone cypionate therapy, including DHT-driven alopecia, acne, oily skin, and evidence-based management strategies.
Testosterone Cypionate in Adults 65 and Older: Safety Profile, Risks, and Monitoring
Evidence-based safety guide for testosterone cypionate use in geriatric men (65+), covering cardiovascular risk, prostate screening, polypharmacy, falls, and monitoring protocols.
Testosterone Cypionate in Special Populations: Transplant, HIV, Chronic Disease, and Beyond
Evidence-based guide to testosterone cypionate use in special populations including organ transplant recipients, people living with HIV, opioid-induced hypogonadism, and chronic kidney disease. Dosing, monitoring, and safety data from primary sources.
Testosterone Cypionate Microdosing Protocols: What the Evidence Actually Shows
A deep dive into testosterone cypionate microdosing protocols, covering pharmacokinetics, dose ranges, injection frequency, clinical trial data, and guideline recommendations for men with hypogonadism.
Testosterone Cypionate Missed-Dose Protocol: What to Do and Why It Matters
A guide to the testosterone cypionate missed-dose protocol, including timing rules, trough pharmacokinetics, and how testosterone cypionate works at the receptor level.
Testosterone Cypionate Monitoring for Adults (30 to 49): Lab Schedule, Target Ranges, and Red Flags
Evidence-based monitoring protocol for testosterone cypionate therapy in men aged 30, 49, including lab timing, hematocrit thresholds, cardiovascular screening, and fertility preservation.
Testosterone Cypionate Monitoring for Older Adults Ages 50 to 64
A guide to testosterone cypionate monitoring protocols for men aged 50 to 64, covering lab timing, cardiovascular risk, hematocrit, prostate surveillance, and dose adjustment thresholds.
Testosterone Cypionate Monitoring for Young Adults (Ages 18 to 29)
A complete clinical guide to testosterone cypionate monitoring for men aged 18 to 29, covering labs, dosing schedules, fertility preservation, and guideline-based safety thresholds.
Testosterone Cypionate Monitoring Schedule: Labs & Exams Your Clinician Should Order
A complete guide to the testosterone cypionate monitoring schedule: which labs to order, when to order them, what targets to hit, and why each test matters for safe, effective TRT.
Testosterone Cypionate Off-Label Uses With Evidence Levels
A guide to testosterone cypionate off-label applications, from female sexual dysfunction to sarcopenia, with trial-level evidence ratings for each use.
Testosterone Cypionate Overdose and Accidental Excess Dose: Clinical Management Guide
A guide to testosterone cypionate overdose, accidental excess dosing, mechanism of action, and clinical management protocols with PubMed-cited evidence.
Testosterone Cypionate Patent History and Generic Timeline
A clinical review of testosterone cypionate's patent history, generic availability, current formulations, and what prescribers and patients should know about access and cost in 2024 and beyond.
Testosterone Cypionate Pharmacogenomics & Genetic Variability: What Your DNA Means for Your TRT Dose
A deep dive into how genetic variants in AR, CYP19A1, SHBG, and CYP3A4/5 alter testosterone cypionate response, dosing, and side-effect risk, with trial citations and clinical decision guidance.
Testosterone Cypionate Pharmacokinetics (ADME): How It Works in the Body
A deep dive into testosterone cypionate absorption, distribution, metabolism, and excretion, with PK data, dosing implications, and clinical trial evidence.
Testosterone Cypionate Real-World Evidence: What Registries and RWE Studies Actually Show
A clinical review of real-world evidence for testosterone cypionate from patient registries, observational cohorts, and post-marketing studies, with PubMed-cited data on outcomes, safety, and long-term effects.
Testosterone Cypionate Regulatory Status: US, EU, Canada, and UK Rules Explained
A country-by-country breakdown of testosterone cypionate's prescription status, controlled-substance scheduling, and availability across the US, EU, Canada, and the UK.
Testosterone Cypionate Safety for Adults Age 50 to 64
A guide to testosterone cypionate safety in men and women aged 50 to 64, covering cardiovascular risks, hematologic effects, dosing, monitoring, and evidence from the T-Trials and beyond.
Testosterone Cypionate Safety in Adults (30 to 49): What the Evidence Shows
A clinical review of testosterone cypionate safety for adults aged 30 to 49, covering cardiovascular risk, hematocrit monitoring, fertility effects, liver considerations, and long-term data from major trials.
Testosterone Cypionate Safety in Young Adults Ages 18 to 29
A guide to testosterone cypionate safety for young adult men ages 18-29, covering fertility, bone health, cardiovascular risk, dosing, and monitoring protocols.
Testosterone Cypionate Safety Signals & FDA Actions: A Clinical Reference
A deep dive into testosterone cypionate's known safety signals, FDA label changes, cardiovascular and hematologic risks, and how the drug works at the molecular level.
Testosterone Cypionate Self-Injection: Route, Supplies and Lab Timing
Prepare for prescribed testosterone cypionate injections with route checks, supply guidance, vial handling, dose-volume math and lab timing.
Testosterone Cypionate Storage, Stability & Shelf Life
Evidence-based guide to testosterone cypionate storage conditions, chemical stability data, shelf life after opening, and proper handling to maintain potency and sterility.
Testosterone Cypionate Travel & Timezone-Shift Protocols
A physician-level guide to managing testosterone cypionate injections across time zones, travel schedules, and storage constraints. Covers dose timing flexibility, cold-chain rules, airport security, and daylight-saving adjustments with primary-literature citations.
Testosterone Cypionate: Complete Drug-Drug Interaction Profile
An evidence-based guide to every clinically significant drug interaction with testosterone cypionate, including mechanisms, severity grades, and management strategies backed by PubMed and FDA sources.
Testosterone Cypionate: How to Safely Stop
A guide to discontinuing testosterone cypionate, covering HPTA suppression, tapering protocols, post-cycle recovery, and what to expect during the transition off TRT.
Testosterone Cypionate: Switching From / To Other Drugs in Class
A clinician-level guide to switching testosterone cypionate to or from other androgen formulations, covering mechanism, pharmacokinetics, dose conversion, washout periods, and monitoring protocols with PubMed-cited evidence.
Testosterone Cypionate: What to Expect Week by Week in Your First Month
A week-by-week guide to testosterone cypionate's first month: what changes when, what the clinical evidence says, and how to manage side effects safely.
Testosterone Mechanism of Action: Injection to Receptor
Testosterone cypionate forms an IM depot, releases free testosterone via esterases, binds AR, converts to DHT or estradiol, and suppresses the HPG axis.
When Did Testosterone Become a Controlled Substance?
Testosterone became a Schedule III controlled substance in 1990. See testosterone cypionate's 1951 synthesis, 1979 FDA approval, and dosing history.